IGF1 and polycystic ovary syndrome: As the baseline sample size calculation for this study was based on the ability to detect an outcome from a previously published study on IGF1 gene expression [6], we are unable to exclude the possibility of a type 1 statistical error in the observed differences in monoacylglycerol 24:0 and capric acid in PCOS and EC tissue compared to controls.